AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2015
Jun 11, 2015
31046_dirs_2015-06-10_2c9c6172-f870-4206-ad7d-6c4104ff2de8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-06-08
Reporting Person: Peltz Stuart Walter (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-08 | Common Stock | M | 60306 | $10.85 | Acquired | 60306 | Direct |
| 2015-06-08 | Common Stock | M | 17170 | $10.85 | Acquired | 77476 | Direct |
| 2015-06-08 | Common Stock | S | 11825 | $53.81 | Disposed | 65651 | Direct |
| 2015-06-08 | Common Stock | S | 36075 | $54.64 | Disposed | 29576 | Direct |
| 2015-06-08 | Common Stock | S | 22300 | $55.71 | Disposed | 7276 | Direct |
| 2015-06-08 | Common Stock | S | 3500 | $56.40 | Disposed | 3776 | Direct |
| 2015-06-09 | Common Stock | M | 26300 | $10.85 | Acquired | 30076 | Direct |
| 2015-06-09 | Common Stock | S | 12500 | $52.89 | Disposed | 17576 | Direct |
| 2015-06-09 | Common Stock | S | 13400 | $53.64 | Disposed | 4176 | Direct |
| 2015-06-09 | Common Stock | S | 400 | $54.29 | Disposed | 3776 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-08 | Stock Option (Right to Buy) | $10.85 | M | 60306 | Disposed | 2023-05-15 | Common Stock (60306) | Direct |
| 2015-06-08 | Stock Option (Right to Buy) | $10.85 | M | 17170 | Disposed | 2023-05-15 | Common Stock (17170) | Direct |
| 2015-06-09 | Stock Option (Right to Buy) | $10.85 | M | 26300 | Disposed | 2023-05-15 | Common Stock (26300) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $27.05 | 2024-01-27 | Common Stock (200000) | 200000 | Direct |
| Stock Option (Right to Buy) | $51.00 | 2025-01-01 | Common Stock (300000) | 300000 | Direct |
| Stock Option (Right to Buy) | $218.4 | 2022-01-10 | Common Stock (416) | 416 | Direct |
| Stock Option (Right to Buy) | $490.8 | 2021-04-27 | Common Stock (541) | 541 | Direct |
| Stock Option (Right to Buy) | $1149.6 | 2020-02-02 | Common Stock (583) | 583 | Direct |
| Stock Option (Right to Buy) | $451.2 | 2019-05-15 | Common Stock (583) | 583 | Direct |
| Stock Option (Right to Buy) | $735.6 | 2018-04-01 | Common Stock (293) | 293 | Direct |
| Stock Option (Right to Buy) | $735.6 | 2018-01-25 | Common Stock (708) | 708 | Direct |
| Stock Option (Right to Buy) | $626.4 | 2017-04-18 | Common Stock (322) | 322 | Direct |
| Stock Option (Right to Buy) | $392.4 | 2016-03-01 | Common Stock (136) | 136 | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person for the primary purposes of diversification.
F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.26 to $54.25 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.26 to $55.18 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.26 to $56.12 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.26 to $56.59 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.23 to $53.21per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F7: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.23 to $54.22 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F8: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.25 to $54.30 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F9: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
F10: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
F11: This option was granted on January 28, 2014 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
F12: This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
F13: This option was granted on January 10, 2012 and vests over four years, with 25% of the shares underlying the option vested on January 1, 2013 and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2013.
F14: Currently exercisable.